MedTrace Logo

Randomized Study Of Novel Enuresis Alarm vs Standard Bedwetting Alarm

NCT05214131 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2026-03-09

Study results available
· View outcomes & findings →

Summary

Identify the dry night rate in patients using the GoGoband® nocturnal enuresis device vs a standard Pflaundler bedwetting alarm.

Conditions

Interventions

DEVICE

gogoband

use of biometric alarm to wake patient prior to wetting

DEVICE

SNEA group

standard bedwetting alarm is used to treat patients, alarm sounds after wetting accident has occurred

Sponsors & Collaborators

  • Southwest pediatric Device Consortium

    collaborator UNKNOWN

  • Food and Drug Administration (FDA)

    collaborator FED

  • Yale University

    lead OTHER

Principal Investigators

  • Israel Franco, MD · Dept of Urology, Yale School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-29
Primary Completion
2025-06-13
Completion
2025-06-13
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05214131 on ClinicalTrials.gov